The store will not work correctly when cookies are disabled.
N-(2-methoxyphenyl)-6-phenylimidazo[1,2-a]pyridine-3-carboxamide
ID: ALA1078542
PubChem CID: 46882742
Max Phase: Preclinical
Molecular Formula: C21H17N3O2
Molecular Weight: 343.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccccc1NC(=O)c1cnc2ccc(-c3ccccc3)cn12
Standard InChI: InChI=1S/C21H17N3O2/c1-26-19-10-6-5-9-17(19)23-21(25)18-13-22-20-12-11-16(14-24(18)20)15-7-3-2-4-8-15/h2-14H,1H3,(H,23,25)
Standard InChI Key: MXJBXTJDRDZTNZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
15.3402 -20.3416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3391 -21.1690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0539 -21.5819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0521 -19.9289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7675 -20.3380 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7723 -21.1644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5598 -21.4153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0417 -20.7438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5520 -20.0781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5690 -19.2550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2909 -18.8556 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8622 -18.8296 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8772 -18.0047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6036 -17.6087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6190 -16.7846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9138 -16.3655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1873 -16.7621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1755 -17.5849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6278 -19.9295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6289 -19.1034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9152 -18.6911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1998 -19.1038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2027 -19.9331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9170 -20.3416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4549 -17.9867 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7467 -17.5636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
12 13 1 0
3 6 1 0
13 14 2 0
1 2 1 0
14 15 1 0
5 4 1 0
15 16 2 0
6 7 2 0
16 17 1 0
7 8 1 0
17 18 2 0
18 13 1 0
8 9 2 0
9 5 1 0
19 20 2 0
4 1 2 0
20 21 1 0
9 10 1 0
21 22 2 0
5 6 1 0
22 23 1 0
10 11 2 0
23 24 2 0
24 19 1 0
1 19 1 0
18 25 1 0
10 12 1 0
25 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 343.39 | Molecular Weight (Monoisotopic): 343.1321 | AlogP: 4.26 | #Rotatable Bonds: 4 |
Polar Surface Area: 55.63 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.39 | CX LogP: 3.26 | CX LogD: 3.26 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.60 | Np Likeness Score: -1.39 |
References
1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |